Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase
17 Jul 2024 //
BUSINESSWIRE
Calithera Receives FDA Fast Track Designation for Sapanisertib
03 Oct 2022 //
GLOBENEWSWIRE
Calithera Biosciences Reports Second Quarter 2022 Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Calithera Bio Shares Progress in Sapanisertib and Mivavotinib Clinical Programs
13 Jul 2022 //
GLOBENEWSWIRE
Calithera Bio Begins Dosing in PII Trial of Sapanisertib in r/r NRF2-msNSCLC
06 Jul 2022 //
GLOBENEWSWIRE
Struggling Calithera nabs 2 cheap cancer assets from Takeda
20 Oct 2021 //
THEPHARMALETTER